- Target
- VPS39
- Reactivity
- Human,Mouse
- Application
- WB
- MW(Calculated)
- 97kD
- MW(Observed)
- --
- Host Species
- Rabbit
- Isotype
- IgG
- Conjugate/Modification
- Unmodified
- Modification site
- --
- Recommended Dilution Ratio
- WB 1:500-2000
- Form
- Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
- Source
- --
- Purification
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
- Purity
- --
- storageCondition
- -15°C to -25°C/1 year(Do not lower than -25°C)
- Concentration
- 1 mg/ml
- Clonality
- Polyclonal
- Clone No.
- --
- Immunogen
- Synthesized peptide derived from human VPS39
- Sequence
- --
- Specificity
- This antibody detects endogenous levels of VPS39 at Human, Mouse
- Gene Name
- VPS39 KIAA0770 TLP VAM6
- Protein Name
- Vam6/Vps39-like protein (TRAP1-like protein;) (hVam6p)
- Other Name
- --
- Organism-1
- Human
- Gene ID-1
- 23339
- SwissProt-1
- Q96JC1
- Organism-2
- Mouse
- Gene ID-2
- 269338
- SwissProt-2
- Q8R5L3
- Organism-3
- --
- Gene ID-3
- --
- SwissProt-3
- --
- Organism-4
- --
- gene ID-4
- --
- SwissProt-4
- --
- Cellular Localization
- Cytoplasm. Lysosome membrane ; Peripheral membrane protein . Late endosome membrane ; Peripheral membrane protein . Colocalizes with TGFBR1 and TGFBR2 in cytoplasmic vesicular structures and most prominently in cortical vesicles. .; (Microbial infection) Sequestrated at the late endosome by SARS coronavirus-2/SARS-CoV-2 ORF3A protein. .